Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

42 results about "Myrothecium roridum" patented technology

Myrothecium roridum is a fungal plant pathogen. Myrotoxin B has been isolated from it.

Submerged fermentation culturing method for medicinal hericium erinaceus mycelium liquid

The invention discloses a submerged fermentation culturing method for a medicinal hericium erinaceus mycelium liquid; compared with a common edible hericium erinaceus, the obtained hericium erinaceus mycelium contains five cancer-fighting substances, seven vitamins, three active cellulases, 18 amino acids, trace elements essential to the human body and on the like except for polysaccharide and polypeptide, wherein contents of cystine, histidine and arginine with larger medicinal values are large; and the 6-7 amino acid identifying points and the protein content (16.65%) of the obtained hericium erinaceus mycelium are respectively 3 times and 1.8 times larger than those of other hericium erinaceus. Infrared spectrum also proves that the hericium erinaceus mycelium also contains a special cancer-fighting organic acid, which is not available in the common hericium erinaceus, except for a hydroxyl ammonia compound. Compared with the traditional manual solid culturing method, the submerged fermentation culturing method disclosed by the invention has the advantages as follows: the breakthrough from manual culture of the hericium erinaceus mycelium to standard and industrial production of the hericium erinaceus mycelium is achieved, the production period is reduced from the 52 days of the traditional culturing method to 14 days, energy is saved and consumption is reduced by 30%, and production cost is reduced by 70%.
Owner:山西旺龙药业集团有限公司

Culture medium of hericium erinaceus, bio-converted mycelium, extract of the bio-converted mycelium, and application of the extract

The invention discloses a culture medium of hericium erinaceus, a bio-converted mycelium, an extract of the bio-converted mycelium, and an application of the extract. The culture medium is prepared by adding a traditional Chinese medicine, sculellaria barbata, to a base culture medium and includes the base culture medium and the sculellaria barbata. 100 parts of the culture medium includes 50-70 parts of the base culture medium and 30-50 parts of the sculellaria barbata, wherein the base culture medium includes, by weight, 350-490 parts of wheat bran, 100-140 parts of corn flour, 45-63 parts of grain bran, 5-7 parts of white sugar and 400-600 parts of water. The bio-converted mycelium is a product that is prepared by inoculating the hericium erinaceus on the culture medium through mycelium conversion. The extract of the bio-converted mycelium is prepared by water-extracting and then pressure-reduced-concentrating the hericium erinaceus mycelium and finally performing vacuum freeze-drying. The extract of the bio-converted mycelium has the effect of resisting gastrointestinal cancer, wherein the effect is significantly better than that of the hericium erinaceus mycelium and the sculellaria barbata independently, so that the extract can be used for preparing an anti-gastrointestinal cancer medicine.
Owner:HUNAN XINHUI PHARMA

Artemisia carvifolia biotransformation mycelium and extract and use thereof

The present invention discloses an artemisia carvifolia biotransformation mycelium and an extract and a use thereof. A preparation method of the artemisia carvifolia biotransformation mycelium is as follows: hericium erinaceus is inoculated into a hericium erinaceus culture medium and cultured at 20-27 DEG C for 30-40 d, and mycelium is taken out and dried to obtain the artemisia carvifolia biotransformation mycelium; every 100 parts of the hericium erinaceus culture medium comprises 50-70 parts of a basal medium and 30-50 parts of artemisia carvifolia; the basal medium comprises the followingcomponents in parts by weight: 350-490 parts of wheat bran, 100-140 parts of corn flour, 50-70 parts of bran coat and 400-600 parts of water; the artemisia carvifolia biotransformation mycelium contains fatty acid substances and ketosteroid substances; and the fatty acid substances comprise palmitic acid, linoleic acid, oleic acid and stearic acid and the ketosteroid substances comprise ergost-7,22-diene-3-one, stigmasta-4-ene-6-alpha-ol-3-one, praeruptorin, scopoletin and byakangelicin. The extract of the artemisia carvifolia biotransformation mycelium has an anti-helicobacter pylori effect,has the effect obviously better than that of hericium erinaceus mycelium or artemisia carvifolia, and can be used for preparing an anti-helicobacter pylori drug.
Owner:HUNAN XINHUI PHARMA

Culture medium for hericium erinaceus, biotransformation mycelium, extract of biotransformation mycelium and application of extract

The invention discloses a culture medium for hericium erinaceus, biotransformation mycelium, an extract of biotransformation mycelium and an application of the extract. The culture medium for hericiumerinaceus is formed by adding traditional Chinese medicine fructus ligustri lucidi to basal culture media and comprises the basal culture media and fructus ligustri lucidi, wherein every 100 parts ofthe culture media comprises 50-70 parts of basal culture media and 30-50 parts of fructus ligustri lucidi; each basal culture medium is prepared from components in parts by weight as follows: 350-490parts of wheat bran, 100-140 parts of corn flour, 50-70 parts of bran and 400-500 parts of water. The biotransformation mycelium is a product obtained through mycelium transformation culture after the culture medium is inoculated with the hericium erinaceus. The extract of the biotransformation mycelium is prepared after hericium erinaceus mycelium is subjected to water extraction, reduced pressure condensation and final vacuum freeze drying. The extract of the biotransformation mycelium has a blood glucose reducing function which is superior to that of hericium erinaceus mycelium or fructusligustri lucidi and can be used for preparing a drug for reducing blood glucose.
Owner:HUNAN XINHUI PHARMA

Method for cultivating hericium erinaceus by using gardenia jasminoides waste

The invention relates to a nutrition medium for cultivation of hericium erinaceus, in particular to a method for cultivating the hericium erinaceus by using gardenia jasminoides waste. 60-80% of gardenia jasminoides residue, 40-50% of rhizoma polygoni cuspidati residue, 10-35% of yellow ginger waste, 0.3-0.6% of sucrose, 0.5-1.5% of urea and 0.5-1.5% of gypsum are sufficiently and evenly stirred,wherein the water content of a culture medium is controlled within 65%-75%; material stirring and bagging are conducted, 200-1000 grams of the culture medium is put into each bag, and sterilization isconducted immediately; high-pressure steam of 121 DEG C is adopted for sterilization for 30-50 minutes, after the bagged culture medium is cooled and inoculated, inoculation of the hericium erinaceusis conducted when the medium is cooled to 25 DEG C, and the hericium erinaceus is cultured and obtained. According to the method, functional components of the gardenia jasminoides and rhizoma polygoni cuspidati are sufficiently used, the method is beneficial for enhancement of oxidation resistance and health care functions of the hericium erinaceus, and large-scale production is facilitated due to less investment and low cost. A large quantity of gardenia yellow substances in the gardenia jasminoides waste are also used, so that the hericium erinaceus is slightly yellow, and various people eat the nutrition medium conveniently.
Owner:长沙爱扬医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products